Literature DB >> 16767672

[Association of MMP1 -1607(1G>2G)single nucleotide polymorphism with susceptibility to lung cancer in Northwestern Chinese population of Han nationality].

Wei-qiang Zhang1, Hua Lin, Yong-an Zhou, Yun-jie Wang, Qing-shu Cheng.   

Abstract

OBJECTIVE: Matrix metalloproteinase 1 (MMP1) plays an important role in the development of lung cancer. This study was to investigate the relation to associate the single nucleotide polymorphism(SNP)in MMP1 gene with the susceptibility to lung cancer in Northwestern Chinese population of Han nationality.
METHODS: By using the methods of polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP), MMP1 -1607(1G>2G) polymorphisms in 150 patients with lung cancer, and 200 healthy controls were detected to evaluate the relationship between different genotypes and susceptibility of lung cancer.
RESULTS: Individuals with 2G/2G genotype had 1.77 fold risk suffering from lung cancer, when compared with ones with 1G/2G and 1G/1G genotypes. Smokers with 2G/2G genotype exhibited 3.20 fold elevated risk for lung cancer (OR 3.20; 95% CI 1.50-6.82).
CONCLUSION: The -1607(1G>2G) in promoter region of MMP1 is associated with susceptibility to lung cancer in Northwestern Chinese population of Han nationality. The genotype 2G/2G enhances the susceptibility to lung cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767672

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  9 in total

1.  The polymorphism MMP1 -1607 (1G>2G) is associated with a significantly increased risk of cancers from a meta-analysis.

Authors:  Lili Lu; Yujiao Sun; Yiqun Li; Ping Wan
Journal:  Tumour Biol       Date:  2014-11-13

2.  Association between matrix metalloproteinase 1 -1607 1G>2G polymorphism and cancer risk: a meta-analysis including 19706 subjects.

Authors:  Guoda Han; Zhijiang Wei; Zhiliang Lu; Haibin Cui; Xiyong Bai; Huai'e Ge; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

3.  MMP1-1607 1G/2G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Xu-Yang Xiao; Xiao-Dong Wang; Dong-Yu Zang
Journal:  Tumour Biol       Date:  2012-09-11

Review 4.  Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.

Authors:  Xiaoying Li; Lianxi Qu; Yu Zhong; Yingjie Zhao; Hongyan Chen; Lu Daru
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-05       Impact factor: 4.553

5.  Association of matrix metalloproteinase family gene polymorphisms with lung cancer risk: logistic regression and generalized odds of published data.

Authors:  Hongxia Li; Xiaoyan Liang; Xuebing Qin; Shaohua Cai; Senyang Yu
Journal:  Sci Rep       Date:  2015-07-22       Impact factor: 4.379

Review 6.  Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review.

Authors:  Edyta Wieczorek; Ewa Jablonska; Wojciech Wasowicz; Edyta Reszka
Journal:  Tumour Biol       Date:  2014-10-29

7.  Association of Matrix Metalloproteinase1-1607 1G>2G Polymorphism and Lung Cancer Risk: An Update by Meta-Analysis.

Authors:  Yue Ma; Xi Yang; Yu-Ping Xie; Cheng Yi; Fen Zhao; Ying Huang
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01

8.  Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk.

Authors:  Patricia González-Arriaga; M Felicitas López-Cima; Ana Fernández-Somoano; Teresa Pascual; Manuel G Marrón; Xose S Puente; Adonina Tardón
Journal:  BMC Cancer       Date:  2008-12-19       Impact factor: 4.430

9.  Matrix metalloproteinase family gene polymorphisms and lung cancer susceptibility: an updated meta-analysis.

Authors:  Xiaoliang Li; Caiyang Liu; Ran Ran; Gaohua Liu; Yanhui Yang; Wenzhuo Zhao; Xiaoyang Xie; Ji Li
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.